CYP1A1 Ile462Val Polymorphism and the Risk of Non-Small Cell Lung Cancer in a Chinese Population. Issue 5 (September 2014)

• Record Type: Journal Article
• Authors: Lin, Jia; He, Bing; Cao, Lei; Zhang, Zhi; Liu, Hongmei; Rao, Juan; Liu, Yingwen; Shao, Shasha; Wang, Guangxia; Zhang, Xuemei
• Is Part Of: Tumori. Volume 100:Issue 5(2014)
• Page Start: 547
• Page End: 552
• Publication Date: 2014-09
• Subjects: CYP1A1 -- genetic variant -- lung cancer -- polymorphism; Cancer -- Periodicals; 616.994
• DOI: 10.1700/1660.18178
• Languages: English
• ISSNs: 0300-8916

Abstract

Aims and Background: Cytochrome P450 (CYP) 1A1 enzyme plays an important role in the metabolism of carcinogens, such as polycyclic aromatic hydrocarbons, nitroaromatics and arylamines. Methods: The study examined the association of CYP1A1 Ile462Val polymorphism with the risk of developing non-small cell lung cancer in a Chinese population. We conducted a case-control study including 526 non-small cell lung cancer cases and 526 cancer-free controls. The odds ratios and 95 confidence intervals were calculated by logistic regression models. Results: Compared with 462Ile/Ile genotype carriers, subjects with CYP1A1 462Ile/Val or Val/Val genotype had a decreased risk of developing non-small cell lung cancer with odds ratios of 0.57 (95% CI, 0.44–0.75) and 0.54 (95% CI, 0.36–0.81), respectively. When stratified by smoking status, the decreased risk of non-small cell lung cancer associated with CYP1A1 462Ile/Val or Val/Val genotype was observed among nonsmokers (OR = 0.62, 95% CI, 0.45–0.87) and among smokers (OR = 0.54, 95% CI, 0.37–0.78). When stratified by smoking-dose, the correlation between CYP1A1 genotypes and the risk of non-small cell lung cancer was detected among light smokers (OR = 0.30, 95% CI, 0.19–0.48) but not among heavy smokers (OR = 0.93, 95% CI, 0.61–1.43). Conclusions: The CYP1A1 Ile462Val variant was associated with a low risk of developing non-small cell lung cancer in a Chinese population.